YL-23174

N/A

Report date: 2024/11/18 17:56:23
NME

Base Information

Drug NameYL-23174
Drug Alias NameYL-23174
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHomeodomain Interacting Protein Kinase 2 inhibitors
TargetsHomeodomain Interacting Protein Kinase 2
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYL-Pharma
China Registration ClassN/A

Develop Information

Active CompaniesYL-Pharma
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A